152 related articles for article (PubMed ID: 29324517)
1. Long-term care of transplant recipients: de novo neoplasms after liver transplantation.
Burra P; Shalaby S; Zanetto A
Curr Opin Organ Transplant; 2018 Apr; 23(2):187-195. PubMed ID: 29324517
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
[TBL] [Abstract][Full Text] [Related]
3. Management of de novo malignancies after liver transplantation.
Pillai AA
Transplant Rev (Orlando); 2015 Jan; 29(1):38-41. PubMed ID: 25510578
[TBL] [Abstract][Full Text] [Related]
4. De novo malignancies after liver transplantation: a major cause of late death.
Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
[TBL] [Abstract][Full Text] [Related]
5. [Occurrence, diagnosis and treatment of de novo gastrointestinal malignancies after organ transplantation].
Ji L; Zhao G
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1206-1210. PubMed ID: 29130236
[TBL] [Abstract][Full Text] [Related]
6. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
[TBL] [Abstract][Full Text] [Related]
7. Burden of de novo malignancy in the liver transplant recipient.
Chandok N; Watt KD
Liver Transpl; 2012 Nov; 18(11):1277-89. PubMed ID: 22887956
[TBL] [Abstract][Full Text] [Related]
8. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
9. Donor-transmitted, donor-derived, and de novo cancer after liver transplant.
Chapman JR; Lynch SV
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():50-4. PubMed ID: 24635793
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of de novo cancer in liver transplant recipients.
Riis TH; Møller DL; Høgh J; Knudsen AD; Rostved AA; Akdag D; Kirkby N; Lassen U; Rasmussen A; Hillingsø JG; Pommergaard HC
APMIS; 2023 Apr; 131(4):135-141. PubMed ID: 36680559
[TBL] [Abstract][Full Text] [Related]
11. Neoplastic disease after liver transplantation: Focus on de novo neoplasms.
Burra P; Rodriguez-Castro KI
World J Gastroenterol; 2015 Aug; 21(29):8753-68. PubMed ID: 26269665
[TBL] [Abstract][Full Text] [Related]
12. De Novo Malignancies After Liver Transplantation: A Single Institution Experience.
Egeli T; Unek T; Ozbilgin M; Agalar C; Derici S; Akarsu M; Unek IT; Aysin M; Bacakoglu A; Astarcıoglu I
Exp Clin Transplant; 2019 Feb; 17(1):74-78. PubMed ID: 29237362
[TBL] [Abstract][Full Text] [Related]
13. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy.
Nasser-Ghodsi N; Mara K; Allen AM; Watt KD
Clin Transplant; 2022 Aug; 36(8):e14714. PubMed ID: 35594161
[TBL] [Abstract][Full Text] [Related]
14. De Novo Malignancies After Liver Transplantation: Experience of a High-Volume Center.
Saglam K; Sahin TT; Ogut Z; Ince V; Usta S; Yilmaz S
J Gastrointest Cancer; 2022 Dec; 53(4):1020-1027. PubMed ID: 34778909
[TBL] [Abstract][Full Text] [Related]
15. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant malignancies in liver transplant recipients.
Akdur A; Kırnap M; Yıldırım S; Altundağ Ö; Moray G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():162-5. PubMed ID: 24635818
[TBL] [Abstract][Full Text] [Related]
17. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation.
Aseni P; Vertemati M; De Carlis L; Sansalone CV; Bonacina E; Minola E; Oreste P; Vizzotto L; Rondinara G
Pathol Int; 2006 Nov; 56(11):712-5. PubMed ID: 17040297
[TBL] [Abstract][Full Text] [Related]
18. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
[TBL] [Abstract][Full Text] [Related]
19. Screening of de novo tumors after liver transplantation.
Herrero JI
J Gastroenterol Hepatol; 2012 Jun; 27(6):1011-6. PubMed ID: 22098062
[TBL] [Abstract][Full Text] [Related]
20. Medical management of the liver transplant recipient.
Stravitz RT; Carl DE; Biskobing DM
Clin Liver Dis; 2011 Nov; 15(4):821-43. PubMed ID: 22032531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
